1. Home
  2. HIHO vs ENLV Comparison

HIHO vs ENLV Comparison

Compare HIHO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

SELL

Current Price

$0.85

Market Cap

4.2M

Sector

Industrials

ML Signal

SELL

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.22

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
ENLV
Founded
1990
2005
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.0M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
HIHO
ENLV
Price
$0.85
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.4K
★ 263.0K
Earning Date
12-14-2026
11-24-2026
Dividend Yield
★ 11.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.16
52 Week High
$2.21
$7.64

Technical Indicators

Market Signals
Indicator
HIHO
ENLV
Relative Strength Index (RSI) 54.13 52.95
Support Level $0.74 $0.55
Resistance Level $0.93 $2.89
Average True Range (ATR) 0.04 0.23
MACD 0.01 -0.02
Stochastic Oscillator 67.58 39.56

Price Performance

Historical Comparison
HIHO
ENLV

About HIHO Highway Holdings Limited

Highway Holdings Ltd manufactures and sells metal, plastic and electronic parts, components, subassemblies and finished products for OEMs and contract manufacturers. Its products are used in photocopiers, laser printers, print cartridges, electrical connectors, electrical circuits and other applications. The Company also offers tooling design and development, metal stamping, screen printing, plastic injection molding, pad printing and electronic assembly of printed circuit boards. It operates through metal stamping and mechanical OEM manufacturing operations and electronic OEM manufacturing operations, with metal stamping and mechanical OEM manufacturing operations generating maximum revenue. The Company generates maximum revenue from Europe.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: